Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of “Buy” from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $30.75.

Several brokerages have issued reports on ASPN. B. Riley upgraded Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, June 25th. Roth Mkm reissued a “buy” rating and issued a $36.00 price objective (up previously from $28.00) on shares of Aspen Aerogels in a report on Wednesday, June 12th. TD Cowen lifted their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock a “buy” rating in a research note on Wednesday, June 5th. Craig Hallum increased their price target on shares of Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a research note on Friday, June 14th. Finally, Piper Sandler lifted their price target on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th.

Insider Transactions at Aspen Aerogels

In related news, CEO Donald R. Young sold 256,944 shares of Aspen Aerogels stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the sale, the chief executive officer now owns 502,855 shares in the company, valued at approximately $14,703,480.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, SVP Keith L. Schilling sold 20,000 shares of the stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $26.84, for a total transaction of $536,800.00. Following the sale, the senior vice president now owns 28,792 shares of the company’s stock, valued at $772,777.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Donald R. Young sold 256,944 shares of Aspen Aerogels stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total transaction of $7,513,042.56. Following the completion of the transaction, the chief executive officer now owns 502,855 shares of the company’s stock, valued at approximately $14,703,480.20. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,776,944 shares of company stock worth $90,299,843. 4.30% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds have recently added to or reduced their stakes in the business. Banque Cantonale Vaudoise increased its position in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after acquiring an additional 1,252 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Aspen Aerogels by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,310 shares of the construction company’s stock worth $341,000 after purchasing an additional 1,339 shares during the period. Price T Rowe Associates Inc. MD raised its position in Aspen Aerogels by 15.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock valued at $257,000 after purchasing an additional 1,938 shares in the last quarter. Thompson Davis & CO. Inc. boosted its stake in shares of Aspen Aerogels by 14.7% in the 4th quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock valued at $381,000 after buying an additional 3,100 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after buying an additional 3,607 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Price Performance

ASPN stock opened at $18.88 on Monday. Aspen Aerogels has a 1 year low of $5.32 and a 1 year high of $31.74. The firm has a market capitalization of $1.44 billion, a PE ratio of -42.91 and a beta of 2.15. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The business has a 50 day simple moving average of $26.02 and a 200-day simple moving average of $20.45.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.